358?369 expression and the development of cardiac hypertrophy. Cardiovasc isoforms in cardiac myocytes and endothelial cells, Cardiovascular Research J Biol Chem Res, vol.5751271, pp.709-71622810, 1996. ,
Caveolin-3 knock-out [23] Gkantiragas I Sphingomyelin-enriched mice develop a progressive cardiomyopathy and show hyperactivamicrodomains at the Golgi complex, Mol Biol Cell J Biol Chem, vol.1223, pp.1819-1861, 2001. ,
Reciprocal regulation of [24 A requirement for endothelial nitric-oxide synthase by Ca21-calmodulin and caveolin. caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth, J Biol Chem Cell, vol.27294, pp.15583-15586625, 1997. ,
Nitric oxide and coronary endothelial dysfunction in Molecular characterization of humans, Cardiovasc Res, vol.2543, pp.572-579, 1999. ,
Hydroxycis-Golgi targeting domain in the caveolin molecule methylglutaryl-coenzyme A reductase inhibition promotes endotheli- 1999, J Cell Biol, vol.145, pp.1443-1459 ,
Loss of caveolae Caveolin-3 null mice dysfunction, and pulmonary defects in caveolin-1 gene-disrupted show a loss of caveolae, changes in the microdomain distribution of mice, Science, vol.293, pp.27-2449, 2001. ,
Caveolin-1 null mice are, Biol Chem, vol.276, pp.21425-21433, 2001. ,
Transgenic overexpression of malities, in skeletal muscle fibers induces a Duchenne-like, pp.38121-38138, 2001. ,
Analysis of the lar dystrophy phenotype? association of proteins with membranes. In: Current protocols in cell 9694, Proc Natl Acad Sci biology, vol.97, p.9689, 2000. ,
Activation of cardiac dystroglycan complex in caveolin-3-deficient limb girdle muscular aldosterone production in rat myocardial infarction: effect of andystrophy, Hum Mol Genet, vol.9, pp.2335-2340, 2000. ,
giotensin II receptor blockade and role in cardiac fibrosis. Circula- [30, receptor subtypes and adenylyl cyclase, pp.2694-2701, 1999. ,
Endothelial diomyocyte caveolae. A mechanism to functionally regulate the nitric oxide synthase is regulated by tyrosine phosphorylation and cAMP signaling pathway interacts with caveolin-1 Caveolin isoforms differ in their [19] Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a N-terminal protein sequence and subcellular distribution. Identificacalmodulin-requiring enzyme tion and epitope mapping of an isoform-specific monoclonal anti- 1990 body probe, J Biol Chem J Biol Chem Proc Natl Acad Sci J Biol Chem, vol.27527187270, pp.41447-4145727237, 1995. ,
Anesthetic concentrations of Reconstitution of an riluzole inhibit neuronal nitric oxide synthase activity, but not endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 expression, in the rat hippocampus, Brain Res, vol.32881, pp.237-240, 2000. ,
Left ventricular lated displacement of eNOS from caveolin-1 function and remodeling after myocardial infarction in aging rats, J Biol Chem, vol.275, pp.22268-22272, 2000. ,
Basal release of nitric oxide Endothelial nitric oxide is decreased in the coronary circulation in patients with heart failure. synthase targeting to caveolae, Specific interactions with caveolin Hypertension, vol.2230, pp.50-56, 1997. ,